Creatine and Creatinine Metabolism - Physiological Reviews

1188 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
160. DAVIS CD, SCHUT HAJ, ADAMSON RH, THORGEIRSSON UP,
THORGEIRSSON SS, AND SNYDERWINE EG. Mutagenic activation
of IQ, PhIP and MeIQx by hepatic microsomes from rat,
monkey and man: low mutagenic activation of MeIQx in cynomolgus
monkeys in vitro reflects low DNA adduct levels in vivo.
Carcinogenesis 14: 61–65, 1993.
161. DAVIS CD, SCHUT HAJ, AND SNYDERWINE EG. Enzymatic phase
II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by
various organs of monkeys and rats. Carcinogenesis 14: 2091–
2096, 1993.
162. DAWSON B, CUTLER M, MOODY A, LAWRENCE S, GOODMAN
C, AND RANDALL N. Effects of oral creatine loading on single and
repeated maximal short sprints. Aust J Sci Med Sports 27: 56–61,
1995.
163. DE DEYN P, MARESCAU B, LORNOY W, BECAUS I, AND LO-
WENTHAL A. Guanidino compounds in uraemic dialysed patients.
Clin Chim Acta 157: 143–150, 1986.
164. DE DEYN PP, D’HOOGE R, PEI YQ, MARESCAU B, AND MAC-
DONALD RL. Possible mechanisms of action of guanidino compounds
as candidate convulsants in uraemia and hyperargininaemia.
In: Guanidino Compounds in Biology and Medicine, edited
by P. P. De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi.
London: Libbey, 1992, p. 409–417.
165. DE DEYN PP, MARESCAU B, CUYKENS JJ, VAN GORP L, LO-
WENTHAL A, AND DE POTTER WP. Guanidino compounds in
serum and cerebrospinal fluid of non-dialyzed patients with renal
insufficiency. Clin Chim Acta 167: 81–88, 1987.
166. DE DEYN PP, MARESCAU B, D’HOOGE R, POSSEMIERS I, NA-
GLER J, AND MAHLER C. Guanidino compound levels in brain
regions of non-dialyzed uremic patients. Neurochem Int 27: 227–
237, 1995.
167. DE DEYN PP, MARESCAU B, AND MACDONALD RL. Epilepsy and
the GABA-hypothesis: a brief review and some examples. Acta
Neurol Belg 90: 65–81, 1990.
168. DE DEYN PP, MARESCAU B, SWARTZ RD, HOGAERTH R, POS-
SEMIERS I, AND LOWENTHAL A. Serum guanidino compound
levels and clearances in uremic patients treated with continuous
ambulatory peritoneal dialysis. Nephron 54: 307–312, 1990.
169. DE DEYN PP, ROBITAILLE P, VANASSE M, QURESHI IA, AND
MARESCAU B. Serum guanidino compound levels in uremic pediatric
patients treated with hemodialysis or continuous cycle
peritoneal dialysis. Nephron 69: 411–417, 1995.
170. DEEG R, RÖDER A, SIEDEL J, GAUHL H, AND ZIEGENHORN J.
Verfahren und Reagenz zur Bestimmung von N-Carbamoylsarcosin
und hierfür geeignetes neues Enzym. German Patent Application
DE 3248145: A1, 1984.
171. DEFALCO AJ AND DAVIES RK. The synthesis of creatine by the
brain of the intact rat. J Neurochem 7: 308–312, 1961.
172. DEGANI H, SHAER A, VICTOR TA, AND KAYE AM. Estrogeninduced
changes in high-energy phosphate metabolism in rat
uterus: 31 P NMR studies. Biochemistry 23: 2572–2577, 1984.
173. DEICKEN RF, CALABRESE G, MERRIN EL, VINOGRADOV S,
FEIN G, AND WEINER MW. Asymmetry of temporal lobe phosphorous
metabolism in schizophrenia: a 31 phosphorous magnetic
resonance spectroscopic imaging study. Biol Psychiatry 38: 279–
286, 1995.
174. DELANGHE J, DE BUYZERE M, AND BAELE G. Creatine inhibits
adenosine diphosphate- and collagen-induced thrombocyte aggregation.
In: Guanidino Compounds in Biology and Medicine,
edited by P. P. De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi.
London: Libbey, 1992, p. 207–211.
175. DELANGHE J, DE SLYPERE J-P, DE BUYZERE M, ROBBRECHT
J, WIEME R, AND VERMEULEN A. Normal reference values for
creatine, creatinine, and carnitine are lower in vegetarians. Clin
Chem 35: 1802–1803, 1989.
176. DELANGHE JR, DE BUYZERE ML, DE SCHEERDER IK, CLUYSE
LP, AND THIERENS HM. Characteristics of creatine release during
acute myocardial infarction, unstable angina, and cardiac surgery.
Clin Chem 41: 928–933, 1995.
177. DELANGHE JR, DE BUYZERE ML, LEROUX-ROELS GG, AND
CLEMENT DL. Can creatine predict further major cardiovascular
events after acute myocardial infarction? Ann Clin Biochem 28:
101–102, 1991.
178. DE MEESTER C. Bacterial mutagenicity of heterocyclic amines
found in heat-processed food. Mutat Res 221: 235–262, 1989.
179. DERRY WB, WILSON L, KHAN IA, LUDUEÑA RF, AND JORDAN
MA. Taxol differentially modulates the dynamics of microtubules
assembled from unfractionated and purified �-tubulin isotypes.
Biochemistry 36: 3554–3562, 1997.
180. DE SAEDELEER M AND MARECHAL G. Chemical energy usage
during isometric twitches of frog sartorius muscle intoxicated
with an isomer of creatine, �-guanidinopropionate. Pflügers Arch
402: 185–189, 1984.
181. DESHMUKH DR, MEERT K, SARNAIK AP, MARESCAU B, AND DE
DEYN PP. Guanidino compound metabolism in arginine-free diet
induced hyperammonemia. Enzyme 45: 128–136, 1991.
182. DESHPANDE SB, FUKUDA A, AND NISHINO H. 3-Nitropropionic
acid increases the intracellular Ca 2� in cultured astrocytes by
reverse operation of the Na � -Ca 2� exchanger. Exp Neurol 145:
38–45, 1997.
183. DE TATA V, CAVALLINI G, POLLERA M, GORI Z, AND BER-
GAMINI E. The induction of mitochondrial myopathy in the rat by
feeding �-guanidinopropionic acid and the reversibility of the
induced mitochondrial lesions: a biochemical and ultrastructural
investigation. Int J Exp Pathol 74: 501–509, 1993.
184. DE TATA V, GORI BERGAMINI Z, AND BERGAMINI E. Changes of
glycogen metabolism in phosphorylcreatine-depleted muscles
taken from rats fed with beta-guanidine propionate. Arch Int
Physiol Biochim 97: 123–132, 1989.
185. DHALLA NS, YATES JC, WALZ DA, MCDONALD VA, AND OLSON
RE. Correlation between changes in the endogenous energy stores
and myocardial function due to hypoxia in the isolated perfused
rat heart. Can J Physiol Pharmacol 50: 333–345, 1972.
185a.D’HOOGE R, PEI Y-Q, MARESCAU B, AND DE DEYN PP. Convulsive
action and toxicity of uremic guanidino compounds: behavioral
assessment and relation to brain concentration in adult mice.
J Neurol Sci 112: 96–105, 1992.
186. DILLON PF AND SEARS PR. Capillary electrophoresis measurement
of tissue metabolites. Am J Physiol Cell Physiol 274: C840–
C845, 1998.
187. DINNING JS AND DAY PL. Creatinuria during recovery from aminopterin-induced
folic acid deficiency in the monkey. J Biol Chem
181: 897–903, 1949.
188. DINNING JS, KEITH CK, PARSONS JT, AND DAY PL. The influence
of pteroylglutamic acid and vitamin B 12 on the metabolism of
pyridine-fed rats. J Nutr 42: 81–88, 1950.
189. DIONISI VICI C, BACHMANN C, GAMBARARA M, COLOMBO JP,
AND SABETTA G. Hyperornithinemia-hyperammonemia-homocitrullinuria
syndrome: low creatine excretion and effect of citrulline,
arginine, or ornithine supplement. Pediatr Res 22: 364–
367, 1987.
190. DIOSZEGHY P. Determination of creatine kinase activity and
related problems in neuromuscular diseases. In: Guanidino Compounds
in Biology and Medicine, edited by P. P. De Deyn, B.
Marescau, V. Stalon, and I. A. Qureshi. London: Libbey, 1992, p.
223–230.
191. DONNELLY WJ AND JOHNSON DB. Creatinine amidohydrolase:
some properties of the partially purified and purified enzyme. Int
J Biochem 8: 11–16, 1977.
192. DOOLEY KL, VON TUNGELN LS, BUCCI T, FU PP, AND KADLU-
BAR FF. Comparative carcinogenicity of 4-aminobiphenyl and the
food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal
B6C3F 1 male mouse. Cancer Lett 62: 205–209, 1992.
193. DÖRNER A, SCHULZE K, RAUCH U, AND SCHULTHEISS H-P.
Adenine nucleotide translocator in dilated cardiomyopathy:
pathophysiological alterations in expression and function. Mol
Cell Biochem 174: 261–269, 1997.
194. DOWN WH, CHASSEAUD LF, AND BALLARD SA. The effect of
intravenously administered phosphocreatine on ATP and phosphocreatine
concentrations in the cardiac muscle of the rat. Arzneim-Forsch/Drug
Res 33: 552–554, 1983.
195. DRESKIN SC. ATP-dependent activation of phospholipase C by
antigen, NECA, Na 3VO 4, and GTP-�-S in permeabilized RBL cell
ghosts: differential augmentation by ATP, phosphoenolpyruvate
and phosphocreatine. Mol Cell Biochem 146: 165–170, 1995.
196. DRESKIN SC, KUHN DE, AND HUANG Y. Phosphoenolpyruvate